179 related articles for article (PubMed ID: 35420472)
21. Structure-Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes.
Davis EH; Barrett ADT
Viral Immunol; 2020; 33(1):12-21. PubMed ID: 31682201
[TBL] [Abstract][Full Text] [Related]
22. Comparative Infections of Zika, Dengue, and Yellow Fever Viruses in Human Cytotrophoblast-Derived Cells Suggest a Gating Role for the Cytotrophoblast in Zika Virus Placental Invasion.
Viettri M; Caraballo G; Sanchez ME; Espejel-Nuñez A; Betanzos A; Ortiz-Navarrete V; Estrada-Gutierrez G; Nava P; Ludert JE
Microbiol Spectr; 2023 Jun; 11(3):e0063023. PubMed ID: 37227282
[TBL] [Abstract][Full Text] [Related]
23. Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.
Douam F; Ploss A
Trends Microbiol; 2018 Nov; 26(11):913-928. PubMed ID: 29933925
[TBL] [Abstract][Full Text] [Related]
24. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.
Engelmann F; Josset L; Girke T; Park B; Barron A; Dewane J; Hammarlund E; Lewis A; Axthelm MK; Slifka MK; Messaoudi I
PLoS Negl Trop Dis; 2014; 8(11):e3295. PubMed ID: 25412185
[TBL] [Abstract][Full Text] [Related]
26. Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.
Ma J; Boudewijns R; Sanchez-Felipe L; Mishra N; Vercruysse T; Buh Kum D; Thibaut HJ; Neyts J; Dallmeier K
Emerg Microbes Infect; 2021 Dec; 10(1):2279-2290. PubMed ID: 34792431
[TBL] [Abstract][Full Text] [Related]
27. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
28. Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.
Piras-Douce F; Raynal F; Raquin A; Girerd-Chambaz Y; Gautheron S; Sanchez MEN; Vangelisti M; Mantel N
Vaccine; 2021 Mar; 39(13):1846-1856. PubMed ID: 33685778
[TBL] [Abstract][Full Text] [Related]
29. A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine.
Yan K; Vet LJ; Tang B; Hobson-Peters J; Rawle DJ; Le TT; Larcher T; Hall RA; Suhrbier A
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32660106
[TBL] [Abstract][Full Text] [Related]
30. Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice.
Tretyakova I; Nickols B; Hidajat R; Jokinen J; Lukashevich IS; Pushko P
Virology; 2014 Nov; 468-470():28-35. PubMed ID: 25129436
[TBL] [Abstract][Full Text] [Related]
31. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
[TBL] [Abstract][Full Text] [Related]
32. Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.
James EA; LaFond RE; Gates TJ; Mai DT; Malhotra U; Kwok WW
J Virol; 2013 Dec; 87(23):12794-804. PubMed ID: 24049183
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine.
Wec AZ; Haslwanter D; Abdiche YN; Shehata L; Pedreño-Lopez N; Moyer CL; Bornholdt ZA; Lilov A; Nett JH; Jangra RK; Brown M; Watkins DI; Ahlm C; Forsell MN; Rey FA; Barba-Spaeth G; Chandran K; Walker LM
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6675-6685. PubMed ID: 32152119
[TBL] [Abstract][Full Text] [Related]
35. Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope.
Lu X; Xiao H; Li S; Pang X; Song J; Liu S; Cheng H; Li Y; Wang X; Huang C; Guo T; Ter Meulen J; Daffis S; Yan J; Dai L; Rao Z; Klenk HD; Qi J; Shi Y; Gao GF
Cell Rep; 2019 Jan; 26(2):438-446.e5. PubMed ID: 30625326
[TBL] [Abstract][Full Text] [Related]
36. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
[TBL] [Abstract][Full Text] [Related]
37. Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
Tottey S; Shoji Y; Jones RM; Chichester JA; Green BJ; Musiychuk K; Si H; Manceva SD; Rhee A; Shamloul M; Norikane J; Guimarães RC; Caride E; Silva ANMR; Simões M; Neves PCC; Marchevsky R; Freire MS; Streatfield SJ; Yusibov V
Am J Trop Med Hyg; 2018 Feb; 98(2):420-431. PubMed ID: 29231157
[TBL] [Abstract][Full Text] [Related]
38. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.
Chambers TJ; Liang Y; Droll DA; Schlesinger JJ; Davidson AD; Wright PJ; Jiang X
J Virol; 2003 Mar; 77(6):3655-68. PubMed ID: 12610141
[TBL] [Abstract][Full Text] [Related]
39. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
[TBL] [Abstract][Full Text] [Related]
40. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]